Inhibition by Rifampin of African Swine Fever Virus Replication in Tissue Culture
AUTOR(ES)
Dardiri, A. H.
RESUMO
Vaccinia virus and African swine fever virus are deoxyribonucleic acid viruses of cytoplasmic origin. The fact that rifampin inhibits the replication of the former virus led to an investigation of its effect on African swine fever virus. The virus used was cytopathogenic to a PK-15 cell line, hemadsorbing in pig leukocyte cultures and lethal to pigs. Rifampin clearly inhibited the multiplication and cytopathogenicity of the virus in PK-15 cells. There was a 1- to 5-log reduction in virus titer depending upon the rifampin concentration, the multiplicity of infection, and the time after infection. Inhibition was greatest at a concentration of 200 μg of rifampin/ml. The drug was not viricidal per se, and the inhibition of virus replication was not due to the cell-granulating effect of rifampin since cultures which were transiently pretreated for long as 90 hr with 200 μg of drug/ml supported viral replication to the same degree as untreated cultures.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=416260Documentos Relacionados
- Requirement of cell nucleus for African swine fever virus replication in Vero cells.
- Inhibition of African swine fever virus binding and infectivity by purified recombinant virus attachment protein p12.
- African swine fever virus attachment protein.
- Cross-links in African swine fever virus DNA.
- The African Swine Fever Virus Thymidine Kinase Gene Is Required for Efficient Replication in Swine Macrophages and for Virulence in Swine
